Literature DB >> 8475472

[Acamprosate--a stabilizing factor in long-term withdrawal of alcoholic patients].

D Ladewig1, T Knecht, P Leher, A Fendl.   

Abstract

In a one-year double-blind-treatment study with acamprosat (six months with and six months without substance) the efficiency of this new medicament could be proved. The number of relapses in the treatment group was significantly lower during the first 30 days with a trend to further 150 days. The substance caused very few side effects.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8475472

Source DB:  PubMed          Journal:  Ther Umsch        ISSN： 0040-5930


  10 in total

1.  The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies.

Authors:  Raye Z Litten; I-Jen P Castle; Daniel Falk; Megan Ryan; Joanne Fertig; Chiung M Chen; Hsiao-ye Yi
Journal:  Alcohol Clin Exp Res       Date:  2013-07-24       Impact factor: 3.455

Review 2.  The development of acamprosate as a treatment against alcohol relapse.

Authors:  Peter R Kufahl; Lucas R Watterson; M Foster Olive
Journal:  Expert Opin Drug Discov       Date:  2014-09-26       Impact factor: 6.098

Review 3.  Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.

Authors:  M I Wilde; A J Wagstaff
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 4.  Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.

Authors:  Barbara J Mason; Charles J Heyser
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

5.  Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.

Authors:  Barbara J Mason; Philippe Lehert
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

6.  Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.

Authors:  Roel Verheul; Philippe Lehert; Peter J Geerlings; Maarten W J Koeter; Wim van den Brink
Journal:  Psychopharmacology (Berl)       Date:  2004-08-19       Impact factor: 4.530

7.  Pharmacoprophylaxis of alcohol dependence: Review and update Part II: Efficacy.

Authors:  Sandeep Grover; Debasish Basu; Gaurav Bhateja
Journal:  Indian J Psychiatry       Date:  2007-01       Impact factor: 1.759

Review 8.  Pharmacotherapy of alcohol dependence: a review of the clinical data.

Authors:  Karl Mann
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis.

Authors:  Francesca Panin; Alessandra T Peana
Journal:  Front Pharmacol       Date:  2019-10-17       Impact factor: 5.810

10.  Safety and efficacy of acamprosate for the treatment of alcohol dependence.

Authors:  Stephanie L Yahn; Lucas R Watterson; M Foster Olive
Journal:  Subst Abuse       Date:  2013-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.